Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes and Moderate Renal Impairment
Crossref DOI link: https://doi.org/10.1007/s13300-016-0184-9
Published Online: 2016-07-11
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perl, Shira
Cook, William
Wei, Cheryl
Iqbal, Nayyar
Hirshberg, Boaz
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2016-07-11
Article History
Received: 4 April 2016
First Online: 11 July 2016